IL6 and plasma cell myeloma: BBR has previously demonstrated modulations to miR-21 of U266 and RPMI-8266 cells, another IgG-producing myeloma cell line, potentially through IL-6/STAT3, and the consequential increase in programmed cell death 4 gene expression [36].